Top Markets
#1 Black Phoenix Black Phoenix +824.20%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +25.37%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#4 Prom Prom +20.14%
#5 Magma Finance Magma Finance +19.82%
#6 SAFEcoin SAFEcoin +19.77%
#7 Beam Beam +18.79%
#8 pipedog pipedog +17.11%
#9 Bless Bless +17.08%
#10 YFSX YFSX +15.57%
Coin of the day
Black Phoenix Black Phoenix
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Nanobiotix S.A. Nanobiotix S.A.

Nanobiotix S.A.

NANO
Kedudukan dalam Saham #5950
Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on... Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is based in Paris, France.
Harga Saham
$45.79
Modal Pasaran
$2.33B
Perubahan (1 hari)
11.43%
Perubahan (1 tahun)
408.10%
Negara
FR
Perdagangan Nanobiotix S.A. (NANO)

Kategori

Healthcare
Hasil untuk Nanobiotix S.A. (NANO)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Nanobiotix S.A., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Nanobiotix S.A. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH